Charlotte Stroes
0000-0001-8976-6843
1 paper found
Refreshing results…
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
Missing publications? Search for publications with a matching author name.